论文信息 - Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel - 字舞流文

Safety of the BNT162b2 COVID‐19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel

I. Lotan | I. Steiner | M. Hellmann | H. Stiebel-Kalish | A. Wilf-Yarkoni | Yitzhak Friedman | Yitzhak Friedman | Adi Wilf-Yarkoni